Antifolate-resistant malaria infections in Mpumalanga.
Durrheim
D N
DN
Sharp
B L
BL
D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use; D018432:Drug Resistance, Multiple; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000453:epidemiology; D011739:Pyrimethamine / Q000627:therapeutic use; D013019:South Africa / Q000453:epidemiology; D013413:Sulfadoxine / Q000627:therapeutic use
D000962:Antimalarials; D005493:Folic Acid Antagonists; D013413:Sulfadoxine; D002738:Chloroquine; D011739:Pyrimethamine